Allan Jonathan 4

What Happened Allan Jonathan, General Counsel and Corporate Secretary of Stoke Therapeutics (STOK), disposed of a total of 8,895 shares in open-market/private sales to satisfy tax withholding tied to the vesting/settlement of restricted stock units. The sales occurred 2026-03-17 and 2026-03-18, generating roughly $285,900 in proceeds across multiple transactions (individual reported lots: 2,476 @ $32.74 = $81,063; 1,791 @ $33.38 = $59,775; 4,222 @ $31.28 = $132,080; 334 @ $31.79 = $10,617; 72 @ $32.85 = $2,365). Transaction code: S (sale).

Key Details

• Dates of disposition: March 17–18, 2026; Form 4 filed March 19, 2026 (timely filing).
• Total shares sold: 8,895; total proceeds ≈ $285,900.
• Reported prices are weighted averages; filing footnotes provide price ranges for the multiple underlying trades.
• Footnote F1: these were issuer‑mandated sales to satisfy tax withholding obligations related to RSU vesting/settlement.
• Shares owned after the transactions are not provided in the excerpt of this filing.

Context These disposals were to cover tax withholding on vested RSUs (a routine administrative transaction) rather than an independent open‑market decision to reduce exposure. Such withholding sales are common and do not, by themselves, signal management sentiment about the company’s outlook.